Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced…
karnottJanuary 18, 2024
The period between “successful” treatment of localized breast cancer and the onset of distant metastasis…
karnottJanuary 16, 2024
The prestigious NIH Director’s New Innovator Award provides significant funding for innovative research that holds…
karnottJanuary 16, 2024
Scientists have appreciated for many decades that T cells have a sophisticated alarm system that…
karnottJanuary 15, 2024
Indapta Therapeutics, Inc., a privately held biotechnology company developing IDP-023, a natural killer (NK) cell…
karnottJanuary 15, 2024
Low-density asymptomatic Plasmodium infections are prevalent in endemic areas, but little is known about their…
karnottJanuary 12, 2024
The overall goal of this initiative is to create cells that can interpret the state…
karnottJanuary 12, 2024
ITHS has a long history of helping researchers prepare for submitting a grant, creating a…
karnottJanuary 11, 2024
PNRI is thrilled to announce the appointment of Dr. Jack Faris as our new interim…
karnottJanuary 11, 2024
